Catalent Pharma Solutions German Facility Successfully Completes FDA Audit

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent Pharma Solutions announces that its integrated dose form development, manufacturing and packaging facility in Schorndorf, Germany, has successfully completed an FDA inspection. This inspection, triggered by pre-approval inspection requirements for two separate products, resulted in three minor observations on FDA Form 483. The Schorndorf facility currently produces products approved by other regulators including those in Germany, Brazil and Taiwan.